Pharmacy School, Massachusetts College of Pharmacy and Health Sciences University, Worcester, Massachusetts, USA.
College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea.
Pain Pract. 2024 Mar;24(3):458-471. doi: 10.1111/papr.13320. Epub 2023 Nov 20.
Chronic opioid use is associated with problematic opioid use, such as opioid abuse. It is important to develop a prediction model for safe opioid use. In this study, we aimed to develop and validate a risk score model for chronic opioid use in opioid-naïve, noncancer patients, using data from a nationwide database.
Data from the National Health Insurance Claims Database in the Republic of Korea from 2016 to 2018 were used, and adult, noncancer patients who were started on non-injectable opioid analgesics (NIOAs) were included. The risk score model was developed using the β coefficient of each variable in the multivariable logistic regression analysis.
Overall, 676,676 noncancer patients were started on NIOAs, of which 65,877 (9.7%) were prescribed NIOAs chronically. Age, baseline healthcare utilization, comorbidities, co-medications, and pattern of first NIOA prescription were identified as risk factors for chronic opioid use. The c-static for the performance of our risk score model was 0.754 (95% confidence interval, 0.750-0.758).
To our knowledge, this is the first tool that can predict chronic opioid use in the Korean population. The model can help physicians examine the risk of chronic opioid use by patients who are started on NIOA.
慢性阿片类药物的使用与阿片类药物滥用等问题性阿片类药物使用有关。开发一种安全使用阿片类药物的预测模型非常重要。在这项研究中,我们旨在使用来自全国数据库的数据,为阿片类药物初治的非癌症患者开发和验证一种慢性阿片类药物使用的风险评分模型。
使用来自韩国国家健康保险索赔数据库的 2016 年至 2018 年的数据,纳入开始使用非注射用阿片类镇痛药(NIOA)的成年非癌症患者。使用多变量逻辑回归分析中每个变量的β系数来开发风险评分模型。
总体而言,有 676,676 名非癌症患者开始使用 NIOA,其中 65,877 名(9.7%)患者长期服用 NIOA。年龄、基线医疗保健利用度、合并症、合并用药和首次 NIOA 处方模式被确定为慢性阿片类药物使用的危险因素。我们的风险评分模型的 c 静态值为 0.754(95%置信区间,0.750-0.758)。
据我们所知,这是第一个可以预测韩国人群慢性阿片类药物使用的工具。该模型可以帮助医生通过开始使用 NIOA 的患者来检查慢性阿片类药物使用的风险。